Fundraising FoxClarus Ventures — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Revelle Aestheticsrevelleaesthetics.cominNov 2021 · $50M
Revelle Aesthetics develops and commercializes the Avéli device, a precision medical technology for cellulite reduction.
FemTechHealthtechMedical DevicesMountain View, US
Eb Bright(Co-Founder and Chief Administrative Officer)inJonathan Podmore(Co-Founder and Chief Technology Officer)inJoshua Makower(Director)Earl A. Bright II(Director)Caroline Van Hove(Executive Officer, Director)in
BoardPhilippe Schaison(Director)in
Co-investorsNew Enterprise Associates (NEA)Runway Growth CapitalWindham Capital Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.